文献速递妇科

宫内节育器使用与宫颈癌风险:系统综述与Meta分析

Intrauterine Device Use and Cervical Cancer Risk: A Systematic Review and Meta-analysis.
PubMed 文献 · Obstet Gynecol · 2017-01-01

该系统综述与Meta分析检索截至2016年7月的多个数据库,从225篇报告中筛选出34项研究,其中17项无公认系统误差来源,16项可纳入Meta分析。使用宫内节育器的女性宫颈癌发生风险较低(汇总比值比0.64,95%CI 0.53-0.77),未发现混杂或发表偏倚可解释该保护效应。

要点

  • 使用宫内节育器的女性宫颈癌风险较低,汇总比值比为0.64(95%CI 0.53-0.77)。
  • 该保护效应在宫颈癌发病率较高的人群中可能更强。
  • 未发现已知风险因素混杂或发表偏倚可解释该保护效应。

核心结论

  • 使用过宫内节育器的女性浸润性宫颈癌发生频率可能约低三分之一。
  • 该可能的非避孕获益在筛查可及性严重受限且宫颈癌发病率高的人群中可能最为有益。

研究设计与样本

  • 系统综述与Meta分析,检索PubMed、Web of Science、ClinicalTrials.gov及科学会议摘要、学位论文目录,检索时间从建库至2016年7月。
  • 从225篇报告的摘要中筛选出34项具有个体水平宫内节育器使用测量和浸润性宫颈癌发生的研究。
  • 经独立评审者对全文严格评估,识别出17项无公认系统误差来源的研究,其中16项可协调纳入Meta分析。

主要发现

  • 使用宫内节育器的女性宫颈癌发生较少,汇总比值比为0.64(95%CI 0.53-0.77)。
  • 已知风险因素混杂和发表偏倚似乎均不能合理解释这一明显的保护效应。
  • 该保护效应在宫颈癌发病率较高的人群中可能更强。

关键数值与推荐

  • 汇总比值比0.64(95%CI 0.53-0.77),比较使用与未使用宫内节育器的女性宫颈癌风险。

临床怎么用

  • 原文未据此给出临床推荐。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE: To estimate the association between use of an intrauterine device (IUD) and risk of cervical cancer by subjecting existing data to critical review, quantitative synthesis, and interpretation. DATA SOURCES: We searched PubMed, Web of Science, ClinicalTrials.gov, and catalogs of scientific meetings and abstracts, theses, and dissertations queried from inception through July 2016. METHODS OF STUDY SELECTION: Examination of abstracts from 225 reports identified 34 studies with individual-level measures of use of an IUD and incident cervical cancer. By critically assessing the full text of these reports, independent reviewers identified 17 studies conducted without recognized sources of systematic error, of which 16 could be harmonized for meta-analysis. TABULATION, INTEGRATION, AND RESULTS: Point and interval estimates of the association between use of an IUD and incident cervical cancer were extracted from original reports into a structured database along with key features of study design and implementation. A random-effects meta-analysis was implemented to quantitatively synthesize extracted estimates and assess likely influence of publication bias, residual confounding, heterogeneity of true effect size, and human papillomavirus prevalence and cervical cancer incidence in source populations. Women who used an IUD experienced less cervical cancer (summary odds ratio 0.64, 95% CI 0.53-0.77). Neither confounding by recognized risk factors nor publication bias seems a plausible explanation for the apparent protective effect, which may be stronger in populations with higher cervical cancer incidence. CONCLUSION: Invasive cervical cancer may be approximately one third less frequent in women who have used an IUD. This possible noncontraceptive benefit could be most beneficial in populations with severely limited access to screening and concomitantly high cervical cancer incidence.

来源:Obstet Gynecol,查看原文。版权归原作者所有。

引用

  1. Cortessis VK, Barrett M, Brown Wade N, et al. Intrauterine Device Use and Cervical Cancer Risk: A Systematic Review and Meta-analysis. Obstet Gynecol. 2017. PMID: 29112647. doi:10.1097/AOG.0000000000002307

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。